FTC's Abbvie Loss Doesn't Apply To Actos Case, Court Told
The plaintiffs accusing Takeda Pharmaceutical Co. and other drugmakers of participating in a pay-for-delay scheme for the Actos diabetes drug argued Tuesday in New York federal court that a recent high-profile...To view the full article, register now.
Already a subscriber? Click here to view full article